Global Vernal Keratoconjunctivitis Market Research Report 2023
Vernal keratoconjunctivitis (VKC) is a rare form of chronic eye allergy of the ocular surface, and one of the most severe forms of allergic conjunctivitis. It, along with the ocular surface, causes corneal complications such as corneal scars, astigmatism and keratoconus, and if left untreated can result in vision loss. An eye-threatening disease, Vernal keratoconjunctivitis, is characterized by the swollen eyelid, tearing red eyes, mucous discharge, intense itching and photophobia. The most common symptoms of the allergy are giant papillae, superficial keratitis, limbitis, corneal epitheliopathy and conjunctival hyperaemia.
According to QYResearch’s new survey, global Vernal Keratoconjunctivitis market is projected to reach US$ 701.8 million in 2029, increasing from US$ 453 million in 2022, with the CAGR of 6.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vernal Keratoconjunctivitis market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Vernal Keratoconjunctivitis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Vernal Keratoconjunctivitis market is projected to reach US$ 701.8 million in 2029, increasing from US$ 453 million in 2022, with the CAGR of 6.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vernal Keratoconjunctivitis market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Vernal Keratoconjunctivitis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Akari Therapeutics
- Allakos
- iCo Therapeutics
- Santen
- Senju Pharmaceutical
- Alcon
- Topical
- Oral
- Hospital Pharmacy
- Retail Pharmacy
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vernal Keratoconjunctivitis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Topical
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Vernal Keratoconjunctivitis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Vernal Keratoconjunctivitis Market Perspective (2018-2029)
2.2 Vernal Keratoconjunctivitis Growth Trends by Region
2.2.1 Global Vernal Keratoconjunctivitis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Vernal Keratoconjunctivitis Historic Market Size by Region (2018-2023)
2.2.3 Vernal Keratoconjunctivitis Forecasted Market Size by Region (2024-2029)
2.3 Vernal Keratoconjunctivitis Market Dynamics
2.3.1 Vernal Keratoconjunctivitis Industry Trends
2.3.2 Vernal Keratoconjunctivitis Market Drivers
2.3.3 Vernal Keratoconjunctivitis Market Challenges
2.3.4 Vernal Keratoconjunctivitis Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Vernal Keratoconjunctivitis Players by Revenue
3.1.1 Global Top Vernal Keratoconjunctivitis Players by Revenue (2018-2023)
3.1.2 Global Vernal Keratoconjunctivitis Revenue Market Share by Players (2018-2023)
3.2 Global Vernal Keratoconjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vernal Keratoconjunctivitis Revenue
3.4 Global Vernal Keratoconjunctivitis Market Concentration Ratio
3.4.1 Global Vernal Keratoconjunctivitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vernal Keratoconjunctivitis Revenue in 2022
3.5 Vernal Keratoconjunctivitis Key Players Head office and Area Served
3.6 Key Players Vernal Keratoconjunctivitis Product Solution and Service
3.7 Date of Enter into Vernal Keratoconjunctivitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 VERNAL KERATOCONJUNCTIVITIS BREAKDOWN DATA BY TYPE
4.1 Global Vernal Keratoconjunctivitis Historic Market Size by Type (2018-2023)
4.2 Global Vernal Keratoconjunctivitis Forecasted Market Size by Type (2024-2029)
5 VERNAL KERATOCONJUNCTIVITIS BREAKDOWN DATA BY APPLICATION
5.1 Global Vernal Keratoconjunctivitis Historic Market Size by Application (2018-2023)
5.2 Global Vernal Keratoconjunctivitis Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Vernal Keratoconjunctivitis Market Size (2018-2029)
6.2 North America Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
6.4 North America Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Vernal Keratoconjunctivitis Market Size (2018-2029)
7.2 Europe Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
7.4 Europe Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Vernal Keratoconjunctivitis Market Size (2018-2029)
8.2 Asia-Pacific Vernal Keratoconjunctivitis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2018-2023)
8.4 Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Vernal Keratoconjunctivitis Market Size (2018-2029)
9.2 Latin America Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
9.4 Latin America Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Vernal Keratoconjunctivitis Market Size (2018-2029)
10.2 Middle East & Africa Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
10.4 Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Akari Therapeutics
11.1.1 Akari Therapeutics Company Detail
11.1.2 Akari Therapeutics Business Overview
11.1.3 Akari Therapeutics Vernal Keratoconjunctivitis Introduction
11.1.4 Akari Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.1.5 Akari Therapeutics Recent Development
11.2 Allakos
11.2.1 Allakos Company Detail
11.2.2 Allakos Business Overview
11.2.3 Allakos Vernal Keratoconjunctivitis Introduction
11.2.4 Allakos Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.2.5 Allakos Recent Development
11.3 iCo Therapeutics
11.3.1 iCo Therapeutics Company Detail
11.3.2 iCo Therapeutics Business Overview
11.3.3 iCo Therapeutics Vernal Keratoconjunctivitis Introduction
11.3.4 iCo Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.3.5 iCo Therapeutics Recent Development
11.4 Santen
11.4.1 Santen Company Detail
11.4.2 Santen Business Overview
11.4.3 Santen Vernal Keratoconjunctivitis Introduction
11.4.4 Santen Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.4.5 Santen Recent Development
11.5 Senju Pharmaceutical
11.5.1 Senju Pharmaceutical Company Detail
11.5.2 Senju Pharmaceutical Business Overview
11.5.3 Senju Pharmaceutical Vernal Keratoconjunctivitis Introduction
11.5.4 Senju Pharmaceutical Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.5.5 Senju Pharmaceutical Recent Development
11.6 Alcon
11.6.1 Alcon Company Detail
11.6.2 Alcon Business Overview
11.6.3 Alcon Vernal Keratoconjunctivitis Introduction
11.6.4 Alcon Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.6.5 Alcon Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vernal Keratoconjunctivitis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Topical
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Vernal Keratoconjunctivitis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Vernal Keratoconjunctivitis Market Perspective (2018-2029)
2.2 Vernal Keratoconjunctivitis Growth Trends by Region
2.2.1 Global Vernal Keratoconjunctivitis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Vernal Keratoconjunctivitis Historic Market Size by Region (2018-2023)
2.2.3 Vernal Keratoconjunctivitis Forecasted Market Size by Region (2024-2029)
2.3 Vernal Keratoconjunctivitis Market Dynamics
2.3.1 Vernal Keratoconjunctivitis Industry Trends
2.3.2 Vernal Keratoconjunctivitis Market Drivers
2.3.3 Vernal Keratoconjunctivitis Market Challenges
2.3.4 Vernal Keratoconjunctivitis Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Vernal Keratoconjunctivitis Players by Revenue
3.1.1 Global Top Vernal Keratoconjunctivitis Players by Revenue (2018-2023)
3.1.2 Global Vernal Keratoconjunctivitis Revenue Market Share by Players (2018-2023)
3.2 Global Vernal Keratoconjunctivitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vernal Keratoconjunctivitis Revenue
3.4 Global Vernal Keratoconjunctivitis Market Concentration Ratio
3.4.1 Global Vernal Keratoconjunctivitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vernal Keratoconjunctivitis Revenue in 2022
3.5 Vernal Keratoconjunctivitis Key Players Head office and Area Served
3.6 Key Players Vernal Keratoconjunctivitis Product Solution and Service
3.7 Date of Enter into Vernal Keratoconjunctivitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 VERNAL KERATOCONJUNCTIVITIS BREAKDOWN DATA BY TYPE
4.1 Global Vernal Keratoconjunctivitis Historic Market Size by Type (2018-2023)
4.2 Global Vernal Keratoconjunctivitis Forecasted Market Size by Type (2024-2029)
5 VERNAL KERATOCONJUNCTIVITIS BREAKDOWN DATA BY APPLICATION
5.1 Global Vernal Keratoconjunctivitis Historic Market Size by Application (2018-2023)
5.2 Global Vernal Keratoconjunctivitis Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Vernal Keratoconjunctivitis Market Size (2018-2029)
6.2 North America Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
6.4 North America Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Vernal Keratoconjunctivitis Market Size (2018-2029)
7.2 Europe Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
7.4 Europe Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Vernal Keratoconjunctivitis Market Size (2018-2029)
8.2 Asia-Pacific Vernal Keratoconjunctivitis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2018-2023)
8.4 Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Vernal Keratoconjunctivitis Market Size (2018-2029)
9.2 Latin America Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
9.4 Latin America Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Vernal Keratoconjunctivitis Market Size (2018-2029)
10.2 Middle East & Africa Vernal Keratoconjunctivitis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2018-2023)
10.4 Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Akari Therapeutics
11.1.1 Akari Therapeutics Company Detail
11.1.2 Akari Therapeutics Business Overview
11.1.3 Akari Therapeutics Vernal Keratoconjunctivitis Introduction
11.1.4 Akari Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.1.5 Akari Therapeutics Recent Development
11.2 Allakos
11.2.1 Allakos Company Detail
11.2.2 Allakos Business Overview
11.2.3 Allakos Vernal Keratoconjunctivitis Introduction
11.2.4 Allakos Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.2.5 Allakos Recent Development
11.3 iCo Therapeutics
11.3.1 iCo Therapeutics Company Detail
11.3.2 iCo Therapeutics Business Overview
11.3.3 iCo Therapeutics Vernal Keratoconjunctivitis Introduction
11.3.4 iCo Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.3.5 iCo Therapeutics Recent Development
11.4 Santen
11.4.1 Santen Company Detail
11.4.2 Santen Business Overview
11.4.3 Santen Vernal Keratoconjunctivitis Introduction
11.4.4 Santen Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.4.5 Santen Recent Development
11.5 Senju Pharmaceutical
11.5.1 Senju Pharmaceutical Company Detail
11.5.2 Senju Pharmaceutical Business Overview
11.5.3 Senju Pharmaceutical Vernal Keratoconjunctivitis Introduction
11.5.4 Senju Pharmaceutical Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.5.5 Senju Pharmaceutical Recent Development
11.6 Alcon
11.6.1 Alcon Company Detail
11.6.2 Alcon Business Overview
11.6.3 Alcon Vernal Keratoconjunctivitis Introduction
11.6.4 Alcon Revenue in Vernal Keratoconjunctivitis Business (2018-2023)
11.6.5 Alcon Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Vernal Keratoconjunctivitis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Topical
Table 3. Key Players of Oral
Table 4. Global Vernal Keratoconjunctivitis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Vernal Keratoconjunctivitis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Vernal Keratoconjunctivitis Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Vernal Keratoconjunctivitis Market Share by Region (2018-2023)
Table 8. Global Vernal Keratoconjunctivitis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Vernal Keratoconjunctivitis Market Share by Region (2024-2029)
Table 10. Vernal Keratoconjunctivitis Market Trends
Table 11. Vernal Keratoconjunctivitis Market Drivers
Table 12. Vernal Keratoconjunctivitis Market Challenges
Table 13. Vernal Keratoconjunctivitis Market Restraints
Table 14. Global Vernal Keratoconjunctivitis Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Vernal Keratoconjunctivitis Market Share by Players (2018-2023)
Table 16. Global Top Vernal Keratoconjunctivitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vernal Keratoconjunctivitis as of 2022)
Table 17. Ranking of Global Top Vernal Keratoconjunctivitis Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Vernal Keratoconjunctivitis Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vernal Keratoconjunctivitis Product Solution and Service
Table 21. Date of Enter into Vernal Keratoconjunctivitis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vernal Keratoconjunctivitis Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Vernal Keratoconjunctivitis Revenue Market Share by Type (2018-2023)
Table 25. Global Vernal Keratoconjunctivitis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Vernal Keratoconjunctivitis Revenue Market Share by Type (2024-2029)
Table 27. Global Vernal Keratoconjunctivitis Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Vernal Keratoconjunctivitis Revenue Market Share by Application (2018-2023)
Table 29. Global Vernal Keratoconjunctivitis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Vernal Keratoconjunctivitis Revenue Market Share by Application (2024-2029)
Table 31. North America Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Vernal Keratoconjunctivitis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 46. Akari Therapeutics Company Detail
Table 47. Akari Therapeutics Business Overview
Table 48. Akari Therapeutics Vernal Keratoconjunctivitis Product
Table 49. Akari Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 50. Akari Therapeutics Recent Development
Table 51. Allakos Company Detail
Table 52. Allakos Business Overview
Table 53. Allakos Vernal Keratoconjunctivitis Product
Table 54. Allakos Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 55. Allakos Recent Development
Table 56. iCo Therapeutics Company Detail
Table 57. iCo Therapeutics Business Overview
Table 58. iCo Therapeutics Vernal Keratoconjunctivitis Product
Table 59. iCo Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 60. iCo Therapeutics Recent Development
Table 61. Santen Company Detail
Table 62. Santen Business Overview
Table 63. Santen Vernal Keratoconjunctivitis Product
Table 64. Santen Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 65. Santen Recent Development
Table 66. Senju Pharmaceutical Company Detail
Table 67. Senju Pharmaceutical Business Overview
Table 68. Senju Pharmaceutical Vernal Keratoconjunctivitis Product
Table 69. Senju Pharmaceutical Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 70. Senju Pharmaceutical Recent Development
Table 71. Alcon Company Detail
Table 72. Alcon Business Overview
Table 73. Alcon Vernal Keratoconjunctivitis Product
Table 74. Alcon Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 75. Alcon Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
Table 1. Global Vernal Keratoconjunctivitis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Topical
Table 3. Key Players of Oral
Table 4. Global Vernal Keratoconjunctivitis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Vernal Keratoconjunctivitis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Vernal Keratoconjunctivitis Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Vernal Keratoconjunctivitis Market Share by Region (2018-2023)
Table 8. Global Vernal Keratoconjunctivitis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Vernal Keratoconjunctivitis Market Share by Region (2024-2029)
Table 10. Vernal Keratoconjunctivitis Market Trends
Table 11. Vernal Keratoconjunctivitis Market Drivers
Table 12. Vernal Keratoconjunctivitis Market Challenges
Table 13. Vernal Keratoconjunctivitis Market Restraints
Table 14. Global Vernal Keratoconjunctivitis Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Vernal Keratoconjunctivitis Market Share by Players (2018-2023)
Table 16. Global Top Vernal Keratoconjunctivitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vernal Keratoconjunctivitis as of 2022)
Table 17. Ranking of Global Top Vernal Keratoconjunctivitis Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Vernal Keratoconjunctivitis Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vernal Keratoconjunctivitis Product Solution and Service
Table 21. Date of Enter into Vernal Keratoconjunctivitis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vernal Keratoconjunctivitis Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Vernal Keratoconjunctivitis Revenue Market Share by Type (2018-2023)
Table 25. Global Vernal Keratoconjunctivitis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Vernal Keratoconjunctivitis Revenue Market Share by Type (2024-2029)
Table 27. Global Vernal Keratoconjunctivitis Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Vernal Keratoconjunctivitis Revenue Market Share by Application (2018-2023)
Table 29. Global Vernal Keratoconjunctivitis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Vernal Keratoconjunctivitis Revenue Market Share by Application (2024-2029)
Table 31. North America Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Vernal Keratoconjunctivitis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Vernal Keratoconjunctivitis Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Vernal Keratoconjunctivitis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Vernal Keratoconjunctivitis Market Size by Country (2024-2029) & (US$ Million)
Table 46. Akari Therapeutics Company Detail
Table 47. Akari Therapeutics Business Overview
Table 48. Akari Therapeutics Vernal Keratoconjunctivitis Product
Table 49. Akari Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 50. Akari Therapeutics Recent Development
Table 51. Allakos Company Detail
Table 52. Allakos Business Overview
Table 53. Allakos Vernal Keratoconjunctivitis Product
Table 54. Allakos Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 55. Allakos Recent Development
Table 56. iCo Therapeutics Company Detail
Table 57. iCo Therapeutics Business Overview
Table 58. iCo Therapeutics Vernal Keratoconjunctivitis Product
Table 59. iCo Therapeutics Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 60. iCo Therapeutics Recent Development
Table 61. Santen Company Detail
Table 62. Santen Business Overview
Table 63. Santen Vernal Keratoconjunctivitis Product
Table 64. Santen Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 65. Santen Recent Development
Table 66. Senju Pharmaceutical Company Detail
Table 67. Senju Pharmaceutical Business Overview
Table 68. Senju Pharmaceutical Vernal Keratoconjunctivitis Product
Table 69. Senju Pharmaceutical Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 70. Senju Pharmaceutical Recent Development
Table 71. Alcon Company Detail
Table 72. Alcon Business Overview
Table 73. Alcon Vernal Keratoconjunctivitis Product
Table 74. Alcon Revenue in Vernal Keratoconjunctivitis Business (2018-2023) & (US$ Million)
Table 75. Alcon Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Vernal Keratoconjunctivitis Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Vernal Keratoconjunctivitis Market Share by Type: 2022 VS 2029
Figure 3. Topical Features
Figure 4. Oral Features
Figure 5. Global Vernal Keratoconjunctivitis Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Vernal Keratoconjunctivitis Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Vernal Keratoconjunctivitis Report Years Considered
Figure 11. Global Vernal Keratoconjunctivitis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Vernal Keratoconjunctivitis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Vernal Keratoconjunctivitis Market Share by Region: 2022 VS 2029
Figure 14. Global Vernal Keratoconjunctivitis Market Share by Players in 2022
Figure 15. Global Top Vernal Keratoconjunctivitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vernal Keratoconjunctivitis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Vernal Keratoconjunctivitis Revenue in 2022
Figure 17. North America Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 19. United States Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 23. Germany Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Vernal Keratoconjunctivitis Market Share by Region (2018-2029)
Figure 31. China Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 39. Mexico Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 43. Turkey Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Akari Therapeutics Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 46. Allakos Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 47. iCo Therapeutics Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 48. Santen Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 49. Senju Pharmaceutical Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 50. Alcon Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Figure 1. Global Vernal Keratoconjunctivitis Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Vernal Keratoconjunctivitis Market Share by Type: 2022 VS 2029
Figure 3. Topical Features
Figure 4. Oral Features
Figure 5. Global Vernal Keratoconjunctivitis Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Vernal Keratoconjunctivitis Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Vernal Keratoconjunctivitis Report Years Considered
Figure 11. Global Vernal Keratoconjunctivitis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Vernal Keratoconjunctivitis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Vernal Keratoconjunctivitis Market Share by Region: 2022 VS 2029
Figure 14. Global Vernal Keratoconjunctivitis Market Share by Players in 2022
Figure 15. Global Top Vernal Keratoconjunctivitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vernal Keratoconjunctivitis as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Vernal Keratoconjunctivitis Revenue in 2022
Figure 17. North America Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 19. United States Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 23. Germany Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Vernal Keratoconjunctivitis Market Share by Region (2018-2029)
Figure 31. China Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 39. Mexico Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Vernal Keratoconjunctivitis Market Share by Country (2018-2029)
Figure 43. Turkey Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Vernal Keratoconjunctivitis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Akari Therapeutics Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 46. Allakos Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 47. iCo Therapeutics Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 48. Santen Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 49. Senju Pharmaceutical Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 50. Alcon Revenue Growth Rate in Vernal Keratoconjunctivitis Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
